Vetmedin-CA1 Chewable Tablets for Dogs - 50 Tablets, 1.25 mg

Description: Vetmedin®–CA1 is indicated for the delay onset of congestive heart failure in dogs with stage B2 preclinical myxomatous mitral valve disease (MMVD).  This medication is for dogs in pre–clinical stage B2 (asymptomatic MMVD with a moderate or loud mitral murmur due to mitral regurgitation and evidence of increased heart size) to delay the onset of clinical signs of heart failure.

Product: Vetmedin®–CA1 Chewable Tablets

For: Dogs

Generic Name: Pimobendan

Brand Name: Vetmedin®–CA1

Drug Class: Inodilator

Manufacturer: Boehringer Ingelheim

Product Description & Form: Vetmedin®–CA1 1.25 mg Chewable Tablets: 16 mm, brown, oval tablet, scored in half, no imprint. (NDC 00010–4610–01) Vetmedin®–CA1 1.25 mg Chewable Tablets Vetmedin®–CA1 5 mg Chewable Tablets: 23 mm, brown, oval tablet, scored in half, no imprint. (NDC 00010–4612–01)Vetmedin®–CA1 5 mg Chewable Tablets

Benefits:

Indicated for the delay onset of congestive heart failure in dogs with stage B2 preclinical myxomatous mitral valve disease (MMVD) For dogs in pre–clinical stage B2 (asymptomatic MMVD with a moderate or loud mitral murmur due to mitral regurgitation and evidence of increased heart size) to delay the onset of clinical signs of heart failure. Conditionally approved by FDA pending a full demonstration of effectiveness under application number 141–556.